Video

Study measures patient rankings of third-line OAB treatments

“We wanted to help provide an understanding of what factors guide patient choice of third line therapy for overactive bladder,” says Anjali Kapur, MD.

In this video, Anjali Kapur, MD, discusses the background and notable findings of the recent Neurourology and Urodynamics paper, “An analysis of factors that influence patient preference of third-line therapy for overactive bladder.” Kapur is a urology resident at Renaissance School of Medicine at Stony Brook University, Stony Brook, New York.

Related Videos
Blur image of hospital corridor | Image Credit: © zephyr_p - stock.adobe.com
Vanita Gaglani, RPT, answers a question during a video interview
William Furuyama, MD, answers a question during a Zoom video interview
Blur image of hospital corridor | Image Credit: © whyframeshot - stock.adobe.com
Woman talking with doctor | Image Credit: © LuneVA/peopleimages.com - stock.adobe.com
Vanita Gaglani, RPT, answers a question during a video interview
Raveen Syan, MD, FPMRS, answers a question during a video interview
Jaspreet S. Sandhu, MD, answers a question during a video interview
Anne Pelletier Cameron, MD, FRCSC, FPMRS, answers a question during a video interview
Andrew C. Peterson, MD, MPH, answers a question during a Zoom interview
© 2025 MJH Life Sciences

All rights reserved.